Multifaceted approach addresses pandemic’s threat to prostate cancer care
|
The coronavirus disease 2019 (COVID-19) pandemic is impacting continuity of care across all areas of medicine. During this challenging period, there are particular obstacles to maintaining delivery of autologous cellular immunotherapy for cancer patients. |
Learn more
|